Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 10/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | MGLL | Q99685 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.36 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.36 |
| ▸ | HSF1 | Q00613 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17014620 | 0.95 | HSF1 (0.39) | ALDH1A1ALDH2ALDH3A1HSF1 | |
| SCHEMBL13858494 | 0.88 | MAPK1 (0.38) | CDC25ACES1ALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL15739410 | 0.87 | CDC25A (0.38) | CDC25ACES1PTGS1PTGS2MGLL | |
| SCHEMBL17148357 | 0.87 | CDC25A (0.38) | CDC25ACES1PTGS1PTGS2MGLL | |
| SCHEMBL15720775 | 0.85 | CDC25A (0.39) | CDC25ACES1PTGS1PTGS2MGLL | |
| SCHEMBL15739853 | 0.85 | CDC25A (0.39) | CDC25ACES1PTGS1PTGS2MGLL | |
| SCHEMBL17148358 | 0.84 | CDC25A (0.38) | CDC25ACES1PTGS1PTGS2MGLL | |
| SCHEMBL15739370 | 0.83 | CDC25A (0.34) | CDC25ACES1PTGS1PTGS2MGLL | |
| SCHEMBL20434454 | 0.82 | PTGS1 (0.45) | CDC25ACES1PTGS1PTGS2MGLL | |
| SCHEMBL20434466 | 0.82 | PTGS1 (0.45) | CDC25ACES1PTGS1PTGS2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9502665-B2 | Organic semiconductor material | E.T.C. S.R.L. (IT) | 2016-11-22 | — | — | US | disclosed |
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | USINVEST LLC | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | OR10J3, TST, AS3MT | CDC25A 1100/4885CES1 4514/4885PTGS1 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.